Balyasny Asset Management »

Janux Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $232k 10k 23.10
2024-09-30 $2.9M 63k 45.43
2022-09-30 $165k 12k 13.54

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Select Sector Spdr Tr Financial (XLF)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Visa Com Cl A Call Option (V)
Wolfspeed Common Stock (WOLF)

View all positions for Balyasny Asset Management

Top funds holding Janux Therapeutics

RA Capital Management
FMR
Henderson Group
BlackRock
Paradigm Biocapital Advisors
Adage Capital Partners GP
Vanguard Group
State Street Corporation
OrbiMed Advisors
Point72 Asset Management
Logos Global Management
Geode Capital Management
Woodline Partners
T. Rowe Price Investment Management
Readystate Asset Management

View all funds holding Janux Therapeutics